✦ LIBER ✦

Expression patterns of specific promyelocytic/retinoic acid receptor-α transcripts in patients with acute promyelocytic leukemia

✍ Scribed by J. LIN; L.-X. HAN; J. QIAN; Y.-L. WANG; D.-M. YAO; Z. QIAN; X.-F. YANG; X.-J. SHENG

Book ID: 111415206
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 191 KB
Volume: 32
Category: Article
ISSN: 1751-5521
DOI: 10.1111/j.1751-553x.2009.01190.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retinoic Acid Receptor α in Acute Promye

Retinoic Acid Receptor α in Acute Promyelocytic Leukemia

✍ C. LAVAU; H. DE THÉ; A. DEJEAN 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

Expression of retinoic acid receptor–tar

Expression of retinoic acid receptor–target genes during retinoic acid therapy for acute promyelocytic leukemia

✍ Takitani, K; Koh, M; Zhu, C L; Inoue, A; Kuno, T; Tanoue, H; Miyake, M; Nakagawa 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Perioperative retinoic acid syndrome in

Perioperative retinoic acid syndrome in a patient with acute promyelocytic leukemia

✍ Nikolay A. Usoltsev; M. Saeed Dhamee 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Detection of PML-retinoic acid receptor-

Detection of PML-retinoic acid receptor-α fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17)

✍ Kazuma Ikeda; Kazunori Sasaki; Taizo Tasaka; Masami Nagai; Koichi Kawanishi; Jir 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

All-trans-retinoic acid-induced erythema

All-trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia

✍ M.C. Kuo; P. Dunn; J.H. Wu; L.Y. Shih 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 212 KB

Pharmacology of all-trans-retinoic acid

Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia

✍ Lanvers, Claudia ;Reinhardt, Dirk ;Dübbers, Angelika ;Wagner-Bohn, Alexandra ;Cr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

## Abstract ## Background Due to severe side effects in virtually all children treated with a standard dose of 45 mg/m^2^/day all‐__trans__‐retinoic acid (ATRA) for acute promyelocytic leukemia (APL) the AML‐BFM study group reduced the dosage to 25 mg/m^2^/day. For the lack of data on the use of A